Arslanian, Silva

The Diagnosis of Polycystic Ovary Syndrome during Adolescence

Witchel, S. F., Oberfield, S., Rosenfield, R. L., Codner, E., Bonny, A., Ibáñez, L., Pena, A., Horikawa, R., Gomez-Lobo, V., Joel, D., et al. (2015) · Hormone Research in Paediatrics

Ovarian function and disordersHypothalamic control of reproductive hormones

Cited by 3,113

The metabolic syndrome in children and adolescents ? an IDF consensus report

Zimmet, P., Alberti, K. G. M., Kaufman, F., Tajima, N., Silink, M., Arslanian, S., Wong, G., Bennett, P., Shaw, J., Caprio, S., et al. (2007) · Pediatric Diabetes

Diabetes, Cardiovascular Risks, and LipoproteinsObesity, Physical Activity, Diet

Cited by 2,013

Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline

Legro, R. S., Arslanian, S. A., Ehrmann, D. A., Hoeger, K. M., Murad, M. H., Pasquali, R., & Welt, C. K. (2013) · The Journal of Clinical Endocrinology & Metabolism

Ovarian function and disordersEndometriosis Research and Treatment

Cited by 1,919

Once-weekly semaglutide in adolescents with obesity

Weghuber, D., Barrett, T., Barrientos-Pérez, M., Gies, I., Hesse, D., Jeppesen, O. K., Kelly, A. S., Mastrandrea, L. D., Sørrig, R., & Arslanian, S. (2022) · New England Journal of Medicine

Pharmacology and Obesity TreatmentObesity, Physical Activity, Diet

Cited by 730

A Randomized, Controlled Trial of Liraglutide for Adolescents with Obesity

Kelly, A. S., Auerbach, P., Barrientos-Perez, M., Gies, I., Hale, P. M., Marcus, C., Mastrandrea, L. D., Prabhu, N., & Arslanian, S. (2020) · New England Journal of Medicine

Pharmacology and Obesity TreatmentObesity, Physical Activity, Diet

Cited by 723

Can clinical factors estimate insulin resistance in type 1 diabetes?

Williams, K. V., Erbey, J. R., Becker, D., Arslanian, S., & Orchard, T. J. (2000) · Diabetes

Diabetes Management and ResearchDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 640

Validation of surrogate estimates of insulin sensitivity and insulin secretion in children and adolescents

Gungor, N., Saad, R., Janosky, J., & Arslanian, S. (2004) · The Journal of Pediatrics

Pancreatic function and diabetesDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 457

Insulin resistance in children: Consensus, perspective, and future directions

Levy-Marchal, C., Arslanian, S., Cutfield, W., Sinaiko, A., Druet, C., Marcovecchio, M. L., & Chiarelli, F. (2010) · The Journal of Clinical Endocrinology & Metabolism

Diabetes, Cardiovascular Risks, and LipoproteinsObesity, Physical Activity, Diet

Cited by 405

Effects of Aerobic Versus Resistance Exercise Without Caloric Restriction on Abdominal Fat, Intrahepatic Lipid, and Insulin Sensitivity in Obese Adolescent Boys

Lee, S., Bacha, F., Hannon, T., Kuk, J. L., Boesch, C., & Arslanian, S. (2012) · Diabetes

Diabetes, Cardiovascular Risks, and LipoproteinsObesity, Physical Activity, Diet

Cited by 398

Effect of Metformin in Pediatric Patients With Type 2 Diabetes

Jones, K. L., Arslanian, S., Peterokova, V. A., Park, J.-S., & Tomlinson, M. J. (2002) · Diabetes Care

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 392

Longitudinal study of physiologic insulin resistance and metabolic changes of puberty

Hannon, T. S., Janosky, J., & Arslanian, S. A. (2006) · Pediatric Research

Growth Hormone and Insulin-like Growth FactorsDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 353

Evaluation and management of youth-onset type 2 diabetes: a position statement by the American Diabetes Association

Arslanian, S., Bacha, F., Grey, M., Marcus, M. D., White, N. H., & Zeitler, P. (2018) · Diabetes Care

Diabetes Management and ResearchDiabetes Treatment and Management

Cited by 349

Early metabolic abnormalities in adolescent girls with polycystic ovarian syndrome

Lewy, V. D., Danadian, K., Witchel, S. F., & Arslanian, S. (2001) · The Journal of Pediatrics

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 298

Metformin Therapy in Obese Adolescents with Polycystic Ovary Syndrome and Impaired Glucose Tolerance: Amelioration of Exaggerated Adrenal Response to Adrenocorticotropin with Reduction of Insulinemia/Insulin Resistance

Arslanian, S. A., Lewy, V., Danadian, K., & Saad, R. (2002) · The Journal of Clinical Endocrinology & Metabolism

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 272

Childhood Obesity Predicts Adult Metabolic Syndrome: The Fels Longitudinal Study

Sun, S. S., Liang, R., Huang, T. T.-K., Daniels, S. R., Arslanian, S., Liu, K., Grave, G. D., & Siervogel, R. M. (2008) · The Journal of Pediatrics

Obesity, Physical Activity, DietDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 252

Youth Type 2 Diabetes

Gungor, N., Bacha, F., Saad, R., Janosky, J., & Arslanian, S. (2005) · Diabetes Care

Pancreatic function and diabetesDiabetes Management and Research

Cited by 186

Impact of insulin and metformin versus metformin alone on β-cell function in youth with impaired glucose tolerance or recently diagnosed type 2 diabetes

The RISE Consortium, Nadeau, K. J., Hannon, T. S., Edelstein, S. L., Arslanian, S. A., Caprio, S., Leschek, E. W., Zeitler, P. S., Buchanan, T. A., Ehrmann, D. A., et al. (2018) · Diabetes Care

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 176

Comparison of Different Definitions of Pediatric Metabolic Syndrome: Relation to Abdominal Adiposity, Insulin Resistance, Adiponectin, and Inflammatory Biomarkers

Lee, S., Bacha, F., Gungor, N., & Arslanian, S. (2008) · The Journal of Pediatrics

Diabetes, Cardiovascular Risks, and LipoproteinsAdipokines, Inflammation, and Metabolic Diseases

Cited by 161

Liraglutide for Children 6 to <12 Years of Age with Obesity — A Randomized Trial

Fox, C. K., Barrientos-Pérez, M., Bomberg, E. M., Dcruz, J., Gies, I., Harder-Lauridsen, N. M., Jalaludin, M. Y., Sahu, K., Weimers, P., Zueger, T., et al. (2025) · New England Journal of Medicine

Pharmacology and Obesity TreatmentObesity, Physical Activity, Diet

Cited by 142

Family history of type 2 diabetes is associated with decreased insulin sensitivity and an impaired balance between insulin sensitivity and insulin secretion in white youth

Arslanian, S. A., Bacha, F., Saad, R., & Gungor, N. (2005) · Diabetes Care

Pancreatic function and diabetesDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 138

The changing face of diabetes in youth: lessons learned from studies of type 2 diabetes

Hannon, T. S., & Arslanian, S. A. (2015) · Annals of the New York Academy of Sciences

Diabetes Management and ResearchDiabetes Treatment and Management

Cited by 137

Insulin sensitivity in African-American children with and without family history of type 2 diabetes.

Danadian, K., Balasekaran, G., Lewy, V, Meza, M. P., Robertson, R., & Arslanian, S. A. (1999) · Diabetes Care

Diabetes, Cardiovascular Risks, and LipoproteinsPancreatic function and diabetes

Cited by 110

Progressive deterioration of β-cell function in obese youth with type 2 diabetes: β-Cell function in youth T2DM

Bacha, F., Gungor, N., Lee, S., & Arslanian, S. A. (2013) · Pediatric Diabetes

Pancreatic function and diabetesDiabetes Treatment and Management

Cited by 106

Insulin Resistance

Lee, S., Gungor, N., Bacha, F., & Arslanian, S. (2007) · Diabetes Care

Diabetes, Cardiovascular Risks, and LipoproteinsAdipokines, Inflammation, and Metabolic Diseases

Cited by 105